Hikma To Divest Phenytoin, Promethazine Injectables To Acquire Baxter Business

X-Gen Pharmaceuticals will purchase the products as part of the FTC-mandated divesture. Without the transaction, Hospira would have been the only other company that sold the two drugs once Hikma acquired Baxter's entire generic injectable business.